Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Analyzing How Elderly Acute Myeloid Leukemia Patients Are Treated, an Institutional Experience

Christopher Allen Willner, II, DO, Mohammad Muhsin Chisti, MD, Michaela Soriano, James Huang, MD

Blood (2019) 134 (Supplement_1): 5849.

https://doi.org/10.1182/blood-2019-121560

Published: 2019

Journal Articles

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Lakshman Vasanthamohan, MD FRCPC, Brent Parker, MD, Joy Mangel, MD FRCPC, Selay Lam, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Chai Wye Phua, MD FRCPC

Blood (2019) 134 (Supplement_1): 4131.

https://doi.org/10.1182/blood-2019-126997

Published: 2019

Journal Articles

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

Areej El-Jawahri, MD, Gregory A. Abel, MD, Joseph Greer, PhD, Amir T. Fathi, MD MD BS, David P. Steensma, MD, Thomas W. LeBlanc, MD MA, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Julia Foster, ANP, Andrew Mark Brunner, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD

Blood (2017) 130 (Supplement 1): 349.

https://doi.org/10.1182/blood.V130.Suppl_1.349.349

Published: 2017

Journal Articles

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Simon J Bulley, Isabel C Lentell, Brendan O'Sullivan, Annabel M Follows, Shalal Sadullah, Mamatha Karanth, MD, Sandra Young Min, James Russell, MA,MBBChir,MRCP, Benjamin J Uttenthal, MD PhD, George A Follows, MD PhD

Blood (2017) 130 (Supplement 1): 4157.

https://doi.org/10.1182/blood.V130.Suppl_1.4157.4157

Published: 2017

Journal Articles

Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome

Blood (2017) 130 (Supplement 1): 2596.

https://doi.org/10.1182/blood.V130.Suppl_1.2596.2596

Published: 2017

Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1422.

https://doi.org/10.1182/blood.V128.22.1422.1422

Published: 2016

Journal Articles

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

Umberto Falcone, MD PhD, Melania Pintilie, MSc, Ri Wang, Vishal Kukreti, MD, John G. Kuruvilla, MD, Jan M.A. Delabie, MD PhD, Richard Tsang, MD, Michael Crump, MD

Blood (2016) 128 (22): 3005.

https://doi.org/10.1182/blood.V128.22.3005.3005

Published: 2016

Journal Articles

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Michaela Kuhlen, MD, Jessica I Hoell, MD, Gabriele Gagnon, MD, Stefan Balzer, MD, Arndt Borkhardt, MD, Gisela Janßen, MD

Blood (2016) 128 (22): 5977.

https://doi.org/10.1182/blood.V128.22.5977.5977

Published: 2016

Journal Articles

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

Blood (2015) 126 (23): 5088.

https://doi.org/10.1182/blood.V126.23.5088.5088

Published: 2015

Journal Articles

Outcomes of Down-Syndrome Associated Acute Lymphoblastic Leukemia in Adults: A Single Center Retrospective Review

Sita D. Bhella, MD, Eshetu G Atenafu, M.Sc., P.Stat., Joseph Brandwein, MD FRCPC, Vikas Gupta, MD FRCP, FRCPath, Johann Hitzler, MD FRCP (C), FAAP, Dina Khalaf, BSc, MSc, MD, Andrzej Lutynski, MD, Aaron D. Schimmer, MD PhD, Andre C Schuh, MD FRCPC, Amr Rostom, MD, Anna Rydlewski, MD, Karen W.L. Yee, MD, Mark D. Minden, MD PhD

Blood (2015) 126 (23): 3717.

https://doi.org/10.1182/blood.V126.23.3717.3717

Published: 2015

Journal Articles

Mantle Cell Lymphoma, Rare Lymphoma Entity: A Result of Lymphoma Registry in Thailand

Blood (2015) 126 (23): 3326.

https://doi.org/10.1182/blood.V126.23.3326.3326

Published: 2015

Journal Articles

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Blood (2014) 124 (21): 3664.

https://doi.org/10.1182/blood.V124.21.3664.3664

Published: 2014

Journal Articles

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Nick van Es, MD, Suzanne Bleker, MD, Ankie Kleinjan, MDPhD, Rene Berckmans, PhD, J W Wilmink, MDPhD, Rienk Nieuwland, PhD, Saskia Middeldorp, MD PhD, Harry R Büller, MD PhD

Blood (2014) 124 (21): 4250.

https://doi.org/10.1182/blood.V124.21.4250.4250

Published: 2014

Journal Articles

The Incidence, Risk Factors, and Prognosis of Recurrent Venous Thromboembolism (VTE) in Patients with Advanced Solid Cancers Receiving Anticoagulation Therapy After the Diagnosis of Index Vte; A Korean Venous Thromboembolism Registry Study.

Ho-Young Yhim, MD, Moon Ju Jang, Won-Il Choi, Yong Cheol Lee, Jeong-Ok Lee, Keun-Wook Lee, Soo-Mee Bang, MD, PhD, Sung Hyun Kim, MD, PhD, Yeo-Kyeoung Kim, Hye Jung Chang, MD, Jae-Yong Kwak, Chang-Yeol Yim

Blood (2012) 120 (21): 2247.

https://doi.org/10.1182/blood.V120.21.2247.2247

Published: 2012

Journal Articles

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Zachariah A. McIver, DO, Thomas Hughes, Pharm D, Sawa Ito, MD, Minoo Battiwalla, MD, MS, Eleftheria K. Koklanaris, BSN, Janice Haggerty, RN, Nancy F. Hensel, BS, A. John Barrett, MD

Blood (2011) 118 (21): 2001.

https://doi.org/10.1182/blood.V118.21.2001.2001

Published: 2011

Journal Articles

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

Raynier Devillier, Roberto Crocchiolo, Jr, Anne Etienne, MD, Thomas Prebet, M.D., Ph.D., Aude Charbonnier, Sabine Furst, Jean El Cheikh, Evelyne D’Incan, Jerome Rey, Catherine Faucher, Didier Blaise, MD, Norbert Vey, MD

Blood (2010) 116 (21): 4514.

https://doi.org/10.1182/blood.V116.21.4514.4514

Published: 2010

Journal Articles

T Cell Responses in Patients Vaccinated with Telomerase (hTERT)-mRNA Transfected Dendritic Cells.

Else Marit Inderberg Suso, Phd, fellow, Anne-Marie Rasmussen, PhD, Steinar Aamdal, MD, PhD, Svein Dueland, MD, PhD, Gustav Gaudernack, PhD, Gunnar Kvalheim, MD, PhD

Blood (2009) 114 (22): 373.

https://doi.org/10.1182/blood.V114.22.373.373

Published: 2009

Journal Articles

Clinical Outcome of Patients with Myelophthisic Anemia Arising From Advanced Gastric Cancer.

Ji Yeon Kwon, Han Jo Kim, Kyoung Ha Kim, Se-Hyung Kim, Sang-Cheol Lee, Hyun Jung Kim, Sang Byung Bae, Chan Kyu Kim, Nam Su Lee, Kyu-Taek Lee, Sung Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Blood (2009) 114 (22): 5095.

https://doi.org/10.1182/blood.V114.22.5095.5095

Published: 2009

Journal Articles

Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases

Sung Hyun Kim, MD, PhD, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Dong Mee Lee, Kyeong Hee Kim, Jin-Yeong Han, Joo- In Park, Jong-Hwan Lee, Kyu-Yeol Lee, Hyo-Jin Kim

Blood (2008) 112 (11): 4068.

https://doi.org/10.1182/blood.V112.11.4068.4068

Published: 2008

Journal Articles

Therapeutic Application of Small Interfering RNA Directed Against bcr-abl Transcripts to a Patient with Imatinib-Resistant Chronic Myeloid Leukemia.

Michael Koldehoff, MD, Dietrich W. Beelen, MD, Ahmet H. Elmaagacli, MD

Blood (2007) 110 (11): 4581.

https://doi.org/10.1182/blood.V110.11.4581.4581

Published: 2007

NARROW

Analyzing How Elderly Acute Myeloid Leukemia Patients Are Treated, an Institutional Experience

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

The Cambridge University Hospitals and Anglia Regional Experience of Using PEP-C As Palliative Chemotherapy in Lymphoma

Patients Who Are Refractory to Ida-FLAG As Initial Induction Chemotherapy for AML Have Persistence of the Dominant Genetic Mutations and a Poor Clinical Outcome

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

Palliative Outpatient Care in Children with Hematologic Malignancies Compared to Solid Tumors

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

Outcomes of Down-Syndrome Associated Acute Lymphoblastic Leukemia in Adults: A Single Center Retrospective Review

Mantle Cell Lymphoma, Rare Lymphoma Entity: A Result of Lymphoma Registry in Thailand

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

The Incidence, Risk Factors, and Prognosis of Recurrent Venous Thromboembolism (VTE) in Patients with Advanced Solid Cancers Receiving Anticoagulation Therapy After the Diagnosis of Index Vte; A Korean Venous Thromboembolism Registry Study.

Second Stem Cell Transplantation (SCT) for Relapsed Leukemia Provides Only Modest Prolongation of Survival

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

T Cell Responses in Patients Vaccinated with Telomerase (hTERT)-mRNA Transfected Dendritic Cells.

Clinical Outcome of Patients with Myelophthisic Anemia Arising From Advanced Gastric Cancer.

Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases

Therapeutic Application of Small Interfering RNA Directed Against bcr-abl Transcripts to a Patient with Imatinib-Resistant Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only